5,6,7,8- tetrahydro- 4H- isoxazolo(4,5- d)azepin- 3- ol

glycine antagonist; see also record for (4,5-c) cpd; RN given refers to parent cpd

Also Known As:

5,6,7,8-tetrahydro-4H-isoxazolo(4,5-d)azepin-3-ol hydrobromide; THAZ

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 08/05/2019 - "Furthermore, BPO-THAZ was successfully utilized to discriminate cancer cells from normal cells showing great promise for cancer diagnosis." 08/05/2019 - "BPO-THAZ can be used to not only evaluate the biothiol level in living HeLa cells upon treatment with H2O2 or anti-cancer drugs but also assess endogenous biothiols in stem cells. "